International Clinical Trial: A study in male and female cancer patients to compare two versions of Olaparib 150 mg tablets and determine whether they work the same way in the body when taken on an empty stomach. Each patient received both tablet versions at different times, and the study measured the drug levels and safety of both products

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116879) titled 'A study in male and female cancer patients to compare two versions of Olaparib 150 mg tablets and determine whether they work the same way in the body when taken on an empty stomach. Each patient received both tablet versions at different times, and the study measured the drug levels and safety of both products' on Sept. 2.

Study Type: BA/BE

Study Design: Randomized, Crossover Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Centralized Blinding and masking:Open Label

Primary Sponsor: Deva Holding A.S.,

Condition: Health Condition 1: ...